Researchers found that adults who took anticholinergic agents for at least three months had a 46% average increase in incident dementia risk, compared with those who didn't use anticholinergics. The meta-analysis, published in Neurourology and Urodynamics, also found use of bladder antimuscarinics for at least three months was tied to a 21% to 65% increased dementia risk.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.